Home Latest Articles
Latest Articles
  • Yingjie NIE, Xingyun HOU, Sufang WANG, Yongli HAN, Wei YAN, Zhiming SHI
    World Clinical Drug. 2025, 46(10): 1086-1090.

    Pharmacetical outpatient clinics represents a new model of pharmaceutical service, which plays a significant role in enhancing the therapeutic effect of patients' drugs, reducing medication risks, and conserving medical resources. In recent years, the opening rate of pharmaceutical outpatient clinics has increased significantly. The types of clinics are diverse, which can meet the medical needs of different patients. The service model and quality of pharmaceutical outpatient clinics are influenced by multiple factors such as region, urban economic scale, hospital level and patients'economic capacity. Based on the ROCCIPI analysis method, the author analyzed the practical situation of pharmaceutical outpatient clinics established in municipal and county-level hospitals in Shanxi province, and proposed optimization strategies, aiming to provide useful references for the construction of pharmaceutical outpatient clinics in other municipal and county-level hospitals.

  • Xinyi XU, Qian ZHAO, Xiaohui MO, Qiang JU
    World Clinical Drug. 2025, 46(9): 869-877.

    Hidradenitis suppurative(HS) is a chronic, recurrent skin disease of follicular inflammatory, accompanied by multiple comorbidities. At present, the pathogenesis of HS remains unclear, with activation of innate immune system and various inflammatory cytokines. In recent years, biological agents and molecular targeted drugs targeting these targets have shown certain efficacy and application prospects for HS. This article reviewed the clinical research progress of different biologics and molecular targeted drugs in the treatment of HS and HS with comorbidities.

  • Bei GUO, Fei WU, Yan QIANG
    World Clinical Drug. 2025, 46(9): 878-883.

    Tumor vaccine therapy activates and enhances the body's natural immune response against tumor cells by utilizing specific antigens present in the tumor microenvironment. These antigens are specifically expressed by tumor-specific proteins only in tumor cells, are not affected by central immune tolerance, and have both high immunogenicity and tumor specificity, making them ideal targets for treatment and a promising direction for personalized immunotherapy. Although the research and application of immunotherapy in malignant melanoma has a long history and has achieved significant results, there are still considerable limitations. This article reviewed the types and mechanisms of tumor vaccines related to malignant melanoma and analyze the effectiveness and limitations of each type of vaccine.

  • Miaoyan FAN, Xinyu WEI, Yingying LU, Junqin MAO, Songpo WANG, Ru'nan QU
    World Clinical Drug. 2025, 46(9): 884-892.
    Objective

    To investigate the mechanism of Huazhuo Chengqi decoction in intervening acute hypertriglyceridemic pancreatitis(AHP) based on network pharmacology and molecular docking.

    Methods

    Components and targets of Huazhuo Chengqi decoction were screened using traditional Chinese medicine systems pharmacology database and analysis platform, traditional Chinese medicine information database, and comparative toxicogenomics database(CTD) database, and the intersected were taken. Cytoscap3.7.2 software was used to construct the network diagram of ''HZCQD-active ingredients-targets'', STRING platform was used to analyze the protein-protein interaction. Metascape platform was performed to conduct enrichment analysis. AutoDock was used to validate the molecular docking.

    Results

    A total of 79 active components in Huazhuo Chengqi decoction were obtained, including quercetin, kaempferol, naringenin, isorhamnetin, and aloe-emodin, ect. Key targets included caspase(CASP)9, CASP3, TP53, Akt1, and nuclear factor(NF)-κB1. These can significantly affect the pathways of lipid regulation and atherosclerosis, nucleotide oligomerization domain-like receptor, mitogen-activated protein kinase, NF-κB and phosphoinositide 3-kinase-Akt signaling pathways. Molecular docking confirmed strong binding between active components and key targets.

    Conclusion

    Huazhuo Chengqi decoction exerts lipid-modulating and anti-inflammatory effects through multi-target and multi-pathway synergy to intervene in AHP, providing a theoretical basis for clinical application.

  • Lei LEI, Zhiyi YANG, Tao HUANG, Jin FAN
    World Clinical Drug. 2025, 46(9): 893-900.
    Objective

    To explore the clinical effect of tirofiban combined with ginkgo biloba diterpene lactone in the treatment of acute cerebral infarction(ACI), and its influence on nerve function and hemorheology.

    Methods

    A total of 150 patients with ACI who received treatment in our hospital from June 2021 to June 2023 were selected, and divided into the control group and combined medication group by simple randomization method, with 75 patients in each group. Both groups received conventional treatment and were also given tirofiban, while the combined group received ginkgo biloba diterpene lactone in addition to the control group. Observe and compare The clinical efficacy, the changes in neurological deficits, daily living abilities, serum inflammatory factor levels, coagulation function indicators, hemorheological indicators and the occurrence of adverse reactions in the two groups were observed and compared.

    Results

    The total effective rate of the combined medication group was higher than the control group(94.67% vs. 80.00%, P<0.05). After treatment, the scores of the National Institutes of Health Stroke Scale, serum C-reactive protein, interleukin-6, and tumor necrosis factor alpha levels in both groups decreased compared to before treatment, and the combined medication group was lower than the control group(P<0.05). The scores of activities of daily living in both groups improved compared to before treatment, and the combined medication group was higher than the control group(P<0.05). After treatment, the fibrinogen, D-dimer, whole blood low-shear viscosity, whole blood high-shear viscosity, and plasma viscosity in both groups decreased compared to before treatment, and those in the combined medication group were lower than the control group(P<0.05). The prothrombin time and activated partial thromboplastin time increased compared to before treatment, and those in the combined medication group were higher than the control group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).

    Conclusion

    Tirofiban combined with ginkgo biloba diterpene lactone in the treatment of ACI can significantly improve the clinical efficacy, effectively improve the neurological impairment and daily living ability of patients, reduce the level of serum inflammatory factors, optimize the coagulation function and hemorheological indexes, and has high safety.

  • Yingying XUE, Jinkun LIU, Weiyi HUANG, Yuhong WANG
    World Clinical Drug. 2025, 46(9): 901-907.
    Objective

    To evaluate the efficacy and safety of Zhangyanming tablets combined with Western medicine in the treatment of primary open angle glaucoma(POAG).

    Methods

    A total of 106 patients with POAG in the ophthalmology outpatient department of our hospital from September 2022 to June 2024 were collected and randomly divided into the control group and the observation group, with 53 cases in each group. The control group was given basic western medical treatment, while the observation group was treated with Zhangyanming tablets in combination with the control group. Both groups were treated continuously for 12 weeks. The best corrected visual acuity(BCVA), intraocular pressure, mean defect degree of visual field, visual field index and average thickness of the retinal nerve fiber layer(RNFL) around the optic disc were compared between the two groups. As well as the linear density and perfusion density of the macula, optic disc and peripapillary vessels, the traditional Chinese medicine(TCM) syndrome score and the total effective rate of treatment were statistically analyzed.

    Results

    A total of 100 patients completed the study, with 50 cases in each of the two groups. After treatment, there were no significant differences in BCVA, intraocular pressure, mean deviation of visual field, and perfusion density of macular, optic disc and peridisc vessels between the two groups(P>0.05). The TCM syndrome score in the observation group were significantly lower than those in the control group(P<0.05), while the visual field index, the average thickness of RNFL, and the linear density of macular, optic disc and peridisc blood vessels in the observation group were significantly higher than those in the control group(P<0.05). The total effective rate of the observation group was higher than that of the control group(82.0% vs. 52.0%, P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).

    Conclusion

    The combination of Zhangyanming tablets and western medicine can significantly improve visual field defects in patients with POAG, increase the average thickness of the RNFL, improve vascular microcirculation in the macula, optic disc and peridisc vessels, effectively alleviate ocular symptoms, and has good safety.

  • Chunyan LI, Yuanxin LI, Feiyi ZHAO, Huiru WANG, Wenjing ZHANG
    World Clinical Drug. 2025, 46(9): 908-914.
    Objective

    To explore the short-term and medium-term efficacy and safety of the Shugan Bushen formula in treating perimenopausal insomnia accompanied by depression.

    Methods

    A total of 92 patients with perimenopausal insomnia accompanied by depression who visited the outpatient department of Shanghai traditional Chinese medicine hospital from August 2022 to May 2023 were selected and randomly divided into the experimental group(Shugan Bushen granules) and the placebo group(Shugan Bushen granules placebo) in a 1∶1 ratio, with 46 cases in each group. the treatment course was 6 weeks. The improvements of sleep, mood, and perimenopausal symptoms, changes in hormone levels were compared, and the occurrence of adverse reactions were observed between the two groups.

    Results

    There were significant differences in the scores of Hamilton depression rating scale(HAMD)-17, insomnia severity index, Kupperman menopause index, Pittsburgh sleep quality index, Menopause depression scale and menopausal specific quality of life questionnaire between the two groups at 6 weeks and 8 weeks of treatment(P<0.05). At the 16th week, there was still a significant difference in HAMD-17 in the experimental group(P<0.05). No obvious abnormalities were observed in safety indicators before and after treatment.

    Conclusion

    The Shugan Bushen formula has certain short-term and medium-term clinical efficacy in improve insomnia, depression, and perimenopausal symptoms in patients with insomnia accompanied by depression, but it can not reverse hormonal changes. The formula exhibits a high safety profile.

  • Jijie JIANG, Shibin HAN, Mengxu LI
    World Clinical Drug. 2025, 46(9): 915-920.
    Objective

    To explore the effect of dapagliflozin combined with valsartan in the treatment of diabetic nephropathy(DN) and its influence on cystatin(Cys)-C.

    Methods

    A total of 110 patients with DN who visited the endocrinology department of Linquan county people's hospital from June 2022 to January 2025 were selected as the research subjects and randomly divided into the observation group and the control group, with 55 cases in each group. The control group was treated with dapagliflozin, while the observation group was treated with dapagliflozin combined with valsartan. The treatment courses were 8 weeks for both groups. After treatment, the clinical efficacy, Cys-C, urinary albumin excretion rate(UAER), β2-globulin(β2-MG), serum creatinine(Scr), fasting palsma glucose(FPG), 2-hour postprandial blood glucose(2hPG), glycosylated hemoglobin(Hb)A1c, erythrocyte sedimentation rate(ESR), C-reactive protein(CRP), serum amyloid protein(SA)A levels and the occurrence of adverse reactions during the treatment period of the two groups were compared.

    Results

    After treatment, the total effective rate of the observation group was higher than that of the control group(87.27% vs. 70.91%, P<0.05). The levels of Cys-C, UAER, β2-MG, Scr, ESR, CRP, SAA, FPG, 2hPG and HbA1c in both groups were lower than those before treatment(P<0.05), and those in the observation group were lower than those in the control group(P<0.05). There was no significant difference in the occurrence of adverse reactions between the two groups(P>0.05).

    Conclusion

    Dapagliflozin combined with valsartan has a better therapeutic effect on DN. It can improve Cys-C and renal function, and contribute to the reduction of inflammatory factors levels.

  • Huiping HU, Wenchun LIU
    World Clinical Drug. 2025, 46(9): 921-926.
    Objective

    To study the effects of levetiracetam combined with perampanel on the discharge index and electroencephalogram(EEG) manifestations of benign childhood epilepsy with centrotemporal spikes(BECT).

    Methods

    A total of 95 children with admitted to the department of pediatric neurorespiratory in our hospital were selected as the research subjects and randomly divided into the control group(n=47) and the study group(n=48). The control group was treated with levetiracetam, while the study group was treated with perampanel in combination on the control group. The clinical effects after treatment, the discharge index during the episode of electroencephalogram, the differences in the α, θ, and δ bands of EEG, and the differences between language intelligence quotient and operational intelligence quotient were compared between the two groups. The occurrence of adverse reactions during the treatment period was also monitored.

    Results

    After treatment, the total effective rate of the control group was lower than that of the study group(78.72% vs. 95.83%, P<0.05). The difference in discharge index of the study group was greater than that of the control group(P<0.05). The improvement rate of the study group was higher than that of the control group(91.67% vs.70.21%, P<0.05). The differences in the α, θ and δ bands of EEG activity in the study group were all higher than those in the control group(P<0.05). The differences in language intelligence quotient scores and operational intelligence quotient scores of the study group were both higher than those of the control group(P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).

    Conclusion

    Levetiracetam combined with perampanel can effectively improve the discharge index of children with , enhance the improvement effect of EEG, promote the recovery of cognitive function, and has good safety.

  • Haixin LAN, Shixian ZHOU, Lanyan SONG, Siming HUANG, Huanqiong LI, Guangxiu HUANG
    World Clinical Drug. 2025, 46(9): 927-931.
    Objective

    To observe the effect of vitamin K on nutritional vitamin D deficiency rickets(VDDR) in children.

    Methods

    A total of 100 children with VDDR admitted to the Department of Pediatrics in our hospital from April 2023 to April 2024 were selected and randomly divided into the control group(n=50, oral vitamin D) and the study group(n=50, oral vitamin D and vitamin K4). Both groups were continuously treated for 2 weeks. The bone mineral density (BMD), bone-specific alkaline phosphatase(B-ALP), and osteocalcin(OC), undercarboxylated OC(ucOC), prostaglandin(PG)E2, tumor necrosis factor(TNF)-α, interleukin(IL)-1β and the occurrence of adverse reactions were compared between the two groups.

    Results

    After treatment, the BMD of the radius and ulna in both groups was higher than that before treatment(P<0.05), and the study group was higher than the control group(P<0.05). After treatment, the levels of B-ALP, OC, ucOC, PGE2, TNF-α and IL-1β in both groups were lower than those before treatment(P<0.05), and the study group were lower than the control group(P<0.05). There was no statistically significant difference in the total incidence of adverse reactions between the two groups(P>0.05).

    Conclusion

    Vitamin K can improve BMD in children with VDDR, regulate the levels of B-ALP, OC, ucOC, PGE2, TNF-α and IL-1β, and does not increase the risk of adverse reactions.

News